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The diagnosis of primary cutaneous B cell
lymphoma can be dif®cult on the basis of histologic
and immunophenotypic features alone. Previous
polymerase chain reaction studies for detection of a
clonal population in nodal B cell lymphomas have
employed different primer pairs with detection sensi-
tivities varying between 34% and 94% but there have
been no comprehensive studies of primary cutaneous
B cell lymphoma. We compared the sensitivity of
different sets of consensus primers to amplify the
CDR3 VDJ region of the immunoglobulin heavy
chain gene in combination with an immunoglobulin
heavy chain joining region consensus primer to
detect a monoclonal population in 39 cases of
primary cutaneous B cell lymphoma. Radiolabeled
products were analyzed with denaturing 6% poly-
acrylamide gel electrophoresis. Sequence analysis
was used to con®rm ampli®cation of clonal immu-
noglobulin heavy chain gene rearrangements and to
establish whether somatic hypermutation can inter-
fere with primer binding. Clonal immunoglobulin
heavy chain gene rearrangements were demonstrated
in 79% of cases (74% with leader sequences, 64%
with FR1, and 45% with FR3 primers). Somatic
hypermutation at primer binding sites was con®rmed
in cases where a false negative result was obtained
with the FR3 primer. Although monoplex polymer-
ase chain reaction ampli®cation using the leader
sequence primers is the most sensitive method for
detecting a clonal population, six primers are
required in six different reactions. Our ®ndings
suggest initial analysis with the FR3 primer and sub-
sequent analysis using leader sequences in negative
cases. Our data indicate that the FR3 consensus
primer alone is not suf®cient for a comprehensive
analysis of primary cutaneous B cell lymphoma. Key
words: polymerase chain reaction/CDR 3 VDJ region/
somatic hypermutation/clonal B-cell population. J Invest
Dermatol 117:984±989, 2001
T
he diagnosis of primary cutaneous B cell lymphoma
(PCBCL) can be dif®cult on the basis of histologic and
immunophenotypic criteria alone (Rijlaarsdam et al,
1990; Ritter et al, 1994). Light chain restriction is not
found universally in B cell lymphomas and the
detection of clonal immunoglobulin gene rearrangements using
southern blot analysis is time-consuming, requires relatively large
amounts of fresh material (a minimum of 10 mg of DNA), and can
only detect a clonal rearrangement if it comprises at least 1%±5% of
the total cell population.
In contrast, the polymerase chain reaction (PCR) is a rapid, cost-
effective technique that can be used to amplify unique V(D)J
rearrangements of the immunoglobulin gene. It requires much
smaller amounts of DNA, and may be used for analysis of archival
paraf®n-embedded material. The splicing of V, D, and J regions,
with random insertion and deletion of nucleotides at the junctions,
is responsible for the diversity of antigen recognition and forms a
DNA segment of unique length (Tonegawa, 1983). Consensus
primers for relatively conserved framework regions (FR1, FR2,
FR3) and the JH region have been used to amplify the third
complementary determining region (CDR3) by PCR. If a
polyclonal lymphoid population is present, numerous variable
sized copies will be produced that will appear as a smear or multiple
bands following electrophoretic separation. A clonal population of
B cells will produce a single discrete product.
Previous PCR studies for the detection of a clonal population in
systemic B cell lymphomas have employed a variety of different
primer pairs and have reported sensitivities as high as 94%
(McCarthy et al, 1990; Trainor et al, 1990; 1991; Deane and
Norton, 1991; Deane et al, 1991; Ramasamy et al, 1992; Diss et al,
1993; Segal et al, 1994a, b; Aubin et al, 1995; Lombardo et al, 1996;
Essop et al, 1997; Derkson et al, 1999). A recent study of PCBCL
employing an FR3 primer, however, found a detection sensitivity
of only 34% (Ritter et al, 1997). This lower sensitivity may re¯ect
somatic hypermutation of the VH region, which results in primer
mismatching and failure to amplify the clonal population of B cells
(Diss et al, 1993; Segal et al, 1994b; Aubin et al, 1995; Lombardo
et al, 1996). Follicle center cell lymphoma, marginal zone
lymphoma, and high-grade large cell lymphomas of extra-nodal
origin exhibit high degrees of somatic hypermutation, which may
explain the lower detection sensitivity in these types of lymphoma
compared to chronic lymphocytic leukemia (B-CLL) and mantle
zone lymphomas (Deane and Norton, 1991; Segal et al, 1994b;
Lombardo et al, 1996; Essop et al, 1997).
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In view of the expected high rate of somatic hypermutation
occurring in PCBCL we undertook this study to compare the
sensitivity of a number of different consensus primer pairs for the
detection of clonal immunoglobulin heavy chain (IgH) gene
rearrangements in proven PCBCL samples.
MATERIALS AND METHODS
Frozen tissue samples from 39 cases of PCBCL were retrieved. The
corresponding histologic and immunohistochemistry sections were
reviewed by three of the authors (FJC, EC, RRJ) and classi®ed
according to the REAL classi®cation (Harris et al, 1994). The diagnosis
of PCBCL was based on diagnostic or compatible histology plus either
light chain restriction or evidence of a clonal B cell population using
southern blot IgH gene analysis. In all cases there had been no evidence
of extra-cutaneous disease at presentation or for 6 mo following diagno-
sis, assessed by adequate staging procedures, which included a complete
physical examination, thoraco-abdominal-pelvic CT scan, and bone
marrow biopsy.
Immunohistochemical staining Detailed immunophenotyping was
performed on routinely ®xed paraf®n-embedded tissue sections using a
panel of monoclonal antibodies that included anti-CD3, anti-CD20,
anti-CD21, anti-CD79a, anti-k, and anti-l, and the monoclonal anti-bcl-
2 protein (Dako, High Wycombe, U.K.).
DNA extraction DNA was extracted from fresh skin biopsy specimens
according to standard procedures by proteinase K digestion and phenol/
chloroform extraction. Control DNA samples were extracted from the
Daudi cell line (monoclonal control) and from six cases of benign
cutaneous lymphoid hyperplasia (polyclonal controls). DNA was also
extracted from involved skin of four cases of systemic B cell lymphoma
that had presented with cutaneous lesions.
Southern blot analysis DNA was digested separately with restriction
enzymes Eco R1 and Hind III and subjected to southern blot analysis.
Filters were hybridized with radiolabeled probes under high stringency
conditions as previously described (Foroni et al, 1984), using a genomic
DNA probe for the JH region of the IgH gene.
IgH gene PCR ampli®cation Three different sets of consensus
primers were used to amplify the CDR3 VDJ region of the IgH gene:
(i) a V region consensus primer corresponding to the third framework
region (FR3) (Deane and Norton, 1990a) in combination with a JH
consensus primer (Deane and Norton, 1990a); (ii) a series of seven V
region consensus primers corresponding to each FR1 region family
(Deane and Norton, 1990b) in combination with a JH consensus primer
(each V region primer was used in a separate monoplex reaction); (iii) a
series of six consensus primers corresponding to the leader segment 5¢ to
each VH region family (Campbell et al, 1992) in combination with a JH
consensus primer (each leader segment primer was used in a monoplex
reaction). The leader sequence primers are slightly longer than those
published because this modi®cation has produced more effective
ampli®cation.
In eight cases in which the V region/JH consensus primers had failed
to detect a clonal IgH gene rearrangement, repeat analysis with V region
primers and a mix of JH primers (JH1, JH2, JH4, JH5 (JH consensus),
JH3, and JH6) was performed. Rarely, JH gene segments are not
recognized by the JH consensus primer. False negative results may also
occur due to somatic hypermutation in the JH region (Aubin et al,
1995).
Figure 1 shows a schematic representation of the rearranged IgH gene
and the relative positions of the ampli®cation primers used in the three
different strategies.
The reaction mix (20 ml ®nal volume) consisted of 1 mg template
DNA, 1 3 PCR buffer (Amersham Pharmacia Biotech, Little Chalfont,
U.K.), 2.5 mM MgCl2, 200 mM [a33P]dCTP, dNTPs, 0.01% Tween
20, 200 nM synthetic oligonucleotide consensus primers (Amersham
Pharmacia Biotech) for the JH region and either FR3, FR1, or leader
sequence regions, and 1 unit of Taq Polymerase (Amersham Pharmacia
Biotech) in combination with taq start antibody (Clontech, Basingstoke,
U.K.). A negative control reaction containing reaction mix but no
template DNA was examined for each PCR assay performed. All PCR
reactions were performed in duplicate for each DNA sample.
Monoplex PCR was performed using a Perkin Elmer thermal cycler
(model 9700, Warrington, U.K.). The annealing temperatures used were
as follows: FR3 primer, 58°C; FR1 primers, 60°C±62°C; leader
sequence primers, 65°C±66°C. The PCR reactions were performed over
30±33 cycles.
The PCR products with appropriate molecular weight markers were
loaded onto 2% agarose gels, subjected to electrophoresis at 100 V, and
stained with ethidium bromide. If ampli®cation was successful, an aliquot
of the radiolabeled PCR products was run on denaturing 6% poly-
acrylamide gels. Formamide (95% formamide, 20 mmol per l ethylene-
diamine tetraacetic acid, 0.05% xylene cyanol FF, 0.05% bromophenol
blue) loading dye was added to each ampli®ed product and denatured at
94°C for 5 min. The samples were put on ice prior to loading onto
denaturing polyacrylamide gels [6% acrylamide (Gibco BRL, Paisley,
U.K.), 7 M urea (United States Biochemicals, Cleveland, OH)]. The gel
was run at 30 W for 2±7 h, depending on the size of the PCR product,
at room temperature in 0.5 3 TBE buffer. Autoradiography was carried
out at room temperature for 24±72 h with an intensifying screen
(Appligene Oncor, Watford, U.K.).
Sequence analysis Sequence analysis was performed on selected
products to con®rm ampli®cation of a clonal immunoglobulin
rearrangement and to identify whether mutations at FR3 primer binding
sites had occurred in cases in which a clonal rearrangement was
demonstrated with leader or FR1 primers but in which a polyclonal
result was obtained with the FR3 primer. Clonal bands were excised
Figure 1. Schematic representation of the rearranged IgH gene
and the relative positions of the ampli®cation primers used in the
three different strategies.
Figure 2. Composite ®gure illustrating autoradiographs of the
IgH gene ®ngerprinting analysis using the different ampli®cation
strategies. (a) FR3 ampli®cation strategy. (b) FR1 ampli®cation strategy
(consensus primer for the VH3 family). (c) Leader sequence ampli®cation
strategy (consensus primer for the VH3 family). Lane 1, a clonal
rearrangement is identi®ed with all three ampli®cation strategies in a
patient with a high-grade PCBCL. Lane 2, polyclonal ampli®cation is
demonstrated in DNA from a low-grade PCBCL. Lanes 3, 4, a clonal
rearrangement is seen with the FR1 and leader sequence primers but not
the FR3 primer in two cases of low-grade PCBCL. Lane 5 demonstrates
a polyclonal ladder (obtained with all primers) from a patient with a
reactive B cell in®ltrate. Lane 6, negative control (reaction mix but no
template DNA).
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from the gel and the product was re-ampli®ed using a biotinylated JH
consensus primer together with the appropriate 5¢ primer. Ampli®cation
was determined by electrophoresis and the remaining PCR product was
passed through a microspin column (Amersham Pharmacia Biotech) to
remove unincorporated primers. The ampli®cation products were then
immobilized on the surface of streptavidin-coated microbeads
(Dynabeads M-280, Dynal, Oslo, Norway). The sequenase chain
termination DNA sequencing method was performed using the
Sequenase Version 2.0 DNA Sequencing Kit (United States
Biochemicals). Products were analyzed by denaturing polyacrylamide gel
electrophoresis and visualized by autoradiography.
Sensitivity of technique To determine the sensitivity of our
technique, DNA obtained from the Daudi B cell line (ECACC no.
89120702) (known to harbour a clonal VH3 family IgH gene
rearrangement) was serially diluted with DNA obtained from a
polyclonal control. PCR/denaturing polyacrylamide gel electrophoresis
was performed using the FR1/VH3 primer in combination with the JH
consensus primer.
RESULTS
Histologic diagnosis of lymphoma Of the 39 cases that made
up the study group, 10 were classi®ed as diffuse large cell
lymphoma (high-grade) and 29 were low-grade PCBCL (21
marginal zone lymphoma, ®ve follicle center lymphoma, three
de®nite lymphoma but dif®cult to classify). The high-grade
lymphomas and all but seven low-grade lymphomas showed
diagnostic histology. Of the seven cases in which histology was
compatible but not diagnostic, three showed a clonal IgH
population by southern blot analysis and the remaining four cases
demonstrated light chain restriction.
Demonstration of monoclonality using the different
consensus primer pairs (Table I)
FR3 + JH consensus primers (Fig 2a) Seventeen of 38 cases (45%)
demonstrated a monoclonal rearrangement of the IgH gene. The
group consisted of seven out of 10 (70%) high-grade lymphomas
but only 10 of 28 (36%) low-grade lymphomas. Only 38 cases were
analyzed using the FR3 primer as DNA was not available in one
case.
FR1 + JH consensus primers (Fig 2b) Twenty-®ve out of 39 (64%)
showed a monoclonal rearrangement using the FR1 series of
consensus primers in combination with the JH consensus primer.
This included six of 10 (60%) high-grade lesions and 19 out of 29
(66%) low-grade lymphomas.
Leader sequences + JH consensus primers (Fig 2c) Twenty-nine of 39
(74%) showed a monoclonal rearrangement using the series of
leader sequence consensus primers in combination with the JH
primer, consisting of eight out of 10 (80%) high-grade and 21 of 29
(72%) low-grade lymphomas.
Overall, a clonal IgH gene rearrangement was found in 31 of 39
(79%) PCBCL, which included nine of 10 (90%) high-grade and 22
of 29 (76%) low-grade lymphomas. In 14 cases (37%) a clonal
rearrangement was identi®ed with all three primer sets, and in six
cases (15%) a clone was detected with only one primer set (®ve
with the leader sequences and one with the FR3 primer). The FR1
primer set did not identify a clonal rearrangement in any cases
where a clone was not detected with either the FR3 or leader
sequence primers. In eight cases where no clonal IgH gene
rearrangement was detected, repeat analysis with a mix of JH
primers failed to detect any further clonal rearrangements.
A clonal IgH rearrangement was detected in all four cases of
systemic B cell lymphoma with cutaneous presentation (three
follicle center lymphoma, one unclassi®able), but with all three
primer sets in only one case. In two cases a clone was detected with
two primer sets (FR3 and FR1 in one case and FR1 and leader
sequences in the other). In the ®nal patient an IgH clone was
detected with the leader sequences alone.
The six cases of reactive cutaneous lymphoid hyperplasia
produced a polyclonal result with all three primer sets.
The sensitivity of this technique for the detection of a clonal IgH
gene rearrangement was approximately 0.5% when DNA from the
Daudi cell line (VH3 family monoclonal control) was serially
diluted with DNA from a reactive B cell in®ltrate.
Table I. Proportion of clonal IgH chain gene rearrangements obtained in cases of PCBCL, systemic B cell lymphoma and
benign cutaneous lymphoid hyperplasia using leader sequences and FR1 and FR3 primers
PCBCL Leaders FR1 FR3 Total
Total 29/39 (74%) 25/39 (64%) 17/38 (45%) 31/39 (79%)
High-grade 8/10 (80%) 6/10 (60%) 7/10 (70%) 9/10 (90%)
Low-grade 21/29 (72%) 19/29 (66%) 10/28 (36%) 22/29 (76%)
Systemic B cell lymphoma 3/4 (75%) 3/4 (75%) 2/4 (50%) 4/4 (100%)
Benign cutaneous 0/6 0/6 0/6 0/6
lymphoid hyperplasia
Table II. Sequence analysis of the FR3 region corresponding to the FR3 primer binding site in nine cases of PCBCLa
Patient Diagnosis VH Family
Closest
germline gene FR3 Clone? Sequence
No. of
mutations
1 MZL 6 V6-01 (DP 74) No AC ACG GCT GTT TAT TAT TGT 2
2 MZL 1 V1-69 (DP10) No AC ACG GCC GTA TAC TAT GGC 5
3 MZL 1 V1-08 (DP 15) No AC ACG GCC GTC TAT GAC TGT 2
4 MZL 3 V3-15 (DP38) No AC ACA GCC GTA TAT ATT GCA 7
5 FCL 1 V1-46 (DP7) No AC ACG GCC ATG TAT TAT TGT 2
6 FCL 4 V4-34 (DP63) No AC ACG GCT ATC TAT TAT TGC 4
7 MZL 3 V3 (1±17) Yes AC ACG GCT GTG TAT TAC TGT 1
8 MZL 1 V1-18 (DP14) Yes AC ACG GCC GTG TAT TAC TGT 0
9 MZL 1 V1-69 (DP10) Yes AC ACG GCC CTA TAT TAC TGT 1
aMZL, marginal zone lymphoma; FCL, follicle center lymphoma nucleotides highlighted in bold = point mutations (when compared with consensus FR3 primer
sequence).
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Comparison with southern blot analysis There were 16
patients with PCBCL showing diagnostic histology that had
previously undergone southern blot analysis. Of the 12 patients
who had a southern blot clonal rearrangement of the IgH chain
gene, 11 were clonal by PCR and one was polyclonal. In the four
patients with germline southern blot analysis, two were clonal by
PCR and two were polyclonal (these patients had immuno-
phenotypic evidence of light chain restriction).
Sequence analysis Sequence analysis of clonal rearrangements
was performed in selected cases to con®rm ampli®cation of the
correct IgH VDJ sequence and to determine whether somatic
hypermutation of the IgH gene was the cause of false negative
results. Discrete bands representing clonal IgH rearrangements
obtained using FR1 or leader sequence primers were sequenced in
nine cases (six with a polyclonal pattern and three with a clonal
pattern using the FR3 primer). Sequences were compared with
germline sequences using the Vbase database (Cook and
Tomlinson, 1995) and DNAplot (Giudicelli et al, 1997) (http://
www.mrc-cpe.cam.ac.uk/imt-doc).
Point mutations of the sequence corresponding to the FR3
primer were identi®ed in the six cases where a polyclonal pattern
had been obtained. The number of mutations varied between two
and seven and in three cases involved the nucleotide at the 3¢ end of
the sequence. In contrast, the three cases sequenced in which a
clonal rearrangement had been identi®ed showed either a single
point mutation (two cases) or no mutations (one case) of the FR3
primer binding site (Table II).
DISCUSSION
The detection of clonal IgH gene rearrangements using either
southern blot analysis or PCR is a valuable method for assessing
clonality in cutaneous B cell in®ltrates where histologic and
immunophenotypic features are not diagnostic (Landa et al, 1993).
To obtain a correct diagnosis, however, highly sensitive and
Table III. Comparison of the published methods and detection sensitivities for clonal rearrangement of the IgH chain
genea
Reference Lymphoma type Gold standard
PCR type
primer pairs
Product
visualization
Sequence
con®rmation
Detection
sensitivity
PCR products analysed on agarose gels
Trainor et al (1990) 14 B-NHL, 9 B-CLL immuno/histology,
SBA
single round
FR3/LJH or VLJH
ethidium bromide no 19/23 (83%)
Deane et al (1991) ALL, B-CLL unique band with single round* ethidium bromide yes 15/16 (94%)
monoplex FR1 primers FR1/JHcon
Ramasamy et al (1992) 9 ALL, 7 NHL,
4 CLL, 2 MM
SBA seminested
FR2/JH primers
ethidium bromide yes 18/22 (82%)
Segal et al (1994a) 43 CLL, 57 SLL, immuno/histology single round ethidium bromide no FR1131/156 (84%)
32 MCL, 17 plasma
cell, 7 hairy cell
FR1,FR3/JHcon FR3150/156 (96%)
Segal et al (1994b) FCCL immuno/histology single round
FR1,FR3/JHcon
ethidium bromide no FR1 27/60 (45%)
FR3 31/60 (52%)
Lombardo et al (1996) intermediate &
high-grade NHL
immuno/histology single round
FR1,FR3/JHcon
ethidium bromide no FR3 43/71 (61%),
FR1 11/15 of those
-ve with FR3
Essop et al (1997) 38 low-grade,
31 high-grade
1LP HD
immuno/histology seminested
FR2,FR3/
JH primers
ethidium bromide no 65/70 (93%)
FR2 58%, FR3 77%
PCR products analysed on polyacrylamide gels
McCarthy et al (1990) 3 FCCL, 4 non-FCCL SBA single round ethidium bromide no 7/9 (78%)
B-NHL, 2 B-CLL VH/JH primers
Trainor et al (1991) 12 B-ALL, 9 B-CLL, SBA seminested ethidium bromide no 39/52 (75%)
21 B-NHL, 10 MM FR3/JH primers
Deane et al (1991) 61 ALL, 55 B-CLL &
B-NHL
immuno/histology single round
FR1/JHcon
SBA with VH
speci®c probes
no 109/116 (94%)
Diss et al (1993) 47 MALT, 23 CB/CC, SBA seminested ethidium bromide no 85/94 (90%)
11 B-CLL, 6 MCL,
4 LPL, 3 splenic MZL
FR2/JH & FR3/JH
primers
FR2 85%,
FR3 80%
Aubin et al (1995) 9 high-grade, 8 FCCL,
9 MCL, 4 non-FCCL,
non-MCL
immuno/histology single round
FR3/JHcon or mix
FR1f/JH primers
FR1c/JH primers
FR2,5,6/JH primers
ethidium bromide no
19/30 (63%)
18/30 (60%)
18/28 (64%)
22/28 (79%)
Ritter et al (1997) small cell & large
cell PCBCL
immuno/histology seminested
FR3/JH primers
ethidium bromide no 12/35 (34%)
Derkson et al (1999) 18 B-CLL, 7 MCL, SBA single round ethidium bromide no 42/70 (60%)
20 FCCL, 5 MALT,
18 DLCL, 1 BL, 1 MM
FR3/JH primers
FR2/JH primers
FR1/JH primers
radiolabeled HRF
¯uorescent GS
radiolabeled HRF
ethidium bromide
45/70 (64%)
48/70 (69%)
54/70 (77%)
45/70 (64%)
aNHL, non-Hodgkin's lymphoma; CLL, chronic lymphocytic leukemia; ALL, acute lymphoblastic leukemia; MM, multiple myeloma; FCCL, follicle center cell lympho-
ma; LP HD, lymphocyte predominant Hodgkin's disease; MALT, mucosa associated lymphoid tissue; CB/CC, centroblastic centrocytic; MCL, mantle zone lymphoma;
LPL, lyphoplasmacytoid lymphoma; MZL, marginal zone lymphoma; DLCL, diffuse large cell lymphoma; BL, Burkitt's lymphoma; SLL, small lymphocytic lymphoma;
*multiplex analysis. All other studies employed primers in a monoplex reaction.
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speci®c PCR methods are required. In this study we used a
monoplex PCR method incorporating three different sets of IgH V
region consensus primers in conjunction with an IgH J region
consensus primer to assess clonality in a set of DNA samples
obtained from lesions of PCBCL.
Overall, with this PCR methodology, we demonstrated that 31
of the 39 (79%) PCBCL showed a clonal IgH gene rearrangement.
We were able to detect a clonal IgH rearrangement in nine of 10
(90%) high-grade and 22 of 29 (76%) low-grade PCBCL. Our
results suggest that use of the leader sequence primers was the most
sensitive detection method. Primers for the FR1 and FR3 regions
were less sensitive, but were able to detect a small number of IgH
clonal rearrangements that were not detected using the leader
sequence primers. There were no cases, however, in which only
the FR1 primers detected an IgH clone. There were only eight
cases of low-grade PCBCL in which all three different primer sets
detected a clonal rearrangement.
A clonal IgH gene rearrangement was not detected in 21% of
PCBCL with any of the primer sets used. Clonal IgH gene
rearrangements may be undetectable, or detected with some primer
pairs but not others, because of somatic hypermutation of
rearranged VH gene segments, which may prevent annealing of
the FR primers and to a lesser extent the JH primer (Diss et al,
1993; Segal et al, 1994b; Aubin et al, 1995; Lombardo et al, 1996).
The primers will anneal to DNA from the reactive B cell
population, however, resulting in ampli®cation of the polyclonal
population alone. Cutaneous B cell lymphomas may also often
consist of a large number of reactive B cells that can reduce the
signal intensity of the monoclonal population, and a very small B
cell clone may therefore be below the threshold for detection
(Trainor et al, 1991; Ritter et al, 1997).
We were able to demonstrate somatic hypermutation at primer
binding sites by sequence analysis of six selected cases in which
clonal rearrangements were detected with leader or FR1 primers
but not the FR3 primer. Between two and seven point mutations
were detected at the FR3 primer binding site. In contrast, three
cases in which a clone was detected using the FR3 primer had
either a single or no point mutation at the same site.
Comparison of the results obtained in our study with the
southern blot analysis data, which were used as one of the ``gold
standards'' for the diagnosis of PCBCL, demonstrated that 11 of 12
samples with a detectable southern blot rearrangement were clonal
by PCR. The detection of a clonal rearrangement using southern
blot analysis is not affected by somatic hypermutation, which is
likely to account for the one negative PCR sample. Interestingly, of
the four patients with germline southern blot analysis but diagnostic
histology and immunophenotypic features, two were clonal by
PCR techniques, con®rming that PCR methods are more
sensitive. Two cases with evidence of light chain restriction did
not demonstrate clonality either by southern blot analysis or PCR
methodology, however, presumably re¯ecting a lack of sensitivity
and somatic hypermutation, respectively.
There are few previous PCR studies analysing the IgH gene in
PCBCL. In 1997, Ritter et al published data on 43 cases of PCBCL
(23 small cell, 15 large cell) using the FR3 primer alone. A clonal
IgH rearrangement was demonstrated in seven of 23 (30%) with
small cell morphology and ®ve of 12 (42%) with large cell
morphology. Overall, these FR3 primer results are similar to our
®ndings. This study was performed on paraf®n-embedded tissue,
and DNA degradation may have prevented ampli®cation of the
IgH gene in 30% of cases because only 70% of cases demonstrated
an ampli®able b-globin gene. More recently Nihal et al compared
IgH PCR assays using multiplex FR1 and FR3 primers and DNA
extracted from fresh tissue in 12 cases of cutaneous B cell
lymphoma (nine PCBCL). In contrast to our ®ndings a clonal
IgH gene rearrangement was detected in 11 of 12 cases with the
FR3 primer but only ®ve of 12 cases with the FR1 primer set
(Nihal et al, 2000).
Previous studies (reviewed in Table III) have used different sets
of primers for detection of clonal IgH gene rearrangements in
systemic B cell lymphoma (McCarthy et al, 1990; Trainor et al,
1990, 1991; Deane and Norton, 1991; Deane et al, 1991;
Ramasamy et al, 1992; Diss et al, 1993; Segal et al, 1994a, b;
Aubin et al, 1995; Lombardo et al, 1996; Essop et al, 1997; Derkson
et al, 1999) and the majority employ primers for the FR3 region
(Trainor et al, 1990; 1991; Diss et al, 1993; Segal et al, 1994a, b;
Aubin et al, 1995; Lombardo et al, 1996; Essop et al, 1997; Derkson
et al, 1999). Some have compared results obtained using a
consensus FR3 primer with those obtained using FR1 (Segal
et al, 1994a, b; Aubin et al, 1995; Lombardo et al, 1996; Derkson
et al, 1999) or FR2 (Diss et al, 1993; Essop et al, 1997; Derkson
et al, 1999) consensus primers and have shown variable rates of
detection, but when the results obtained with different primer sets
are combined, the overall detection sensitivity is increased (Diss
et al, 1993; Segal et al, 1994a, b; Lombardo et al, 1996; Essop et al,
1997; Derkson et al, 1999), which concurs with our results. The
detection sensitivities are much lower in those lymphomas derived
from germinal center and post germinal center B cells (MALT,
follicle center cell, and high-grade diffuse large cell lymphomas)
that exhibit high degrees of somatic hypermutation (Diss et al,
1993; Segal et al, 1994b; Aubin et al, 1995; Lombardo et al, 1996;
Essop et al, 1997; Ritter et al, 1997; Derkson et al, 1999).
Various PCR methods for analysis of the IgH gene have been
published. Many studies employ semi-nested PCR techniques
(Trainor et al, 1991; Ramasamy et al, 1992; Diss et al, 1993; Essop
et al, 1997; Ritter et al, 1997) to increase sensitivity but speci®city
can be reduced. We used a single-round monoplex PCR reaction
to increase speci®city in combination with a highly sensitive
electrophoretic technique. Some studies have only used agarose gels
for analysis of PCR products (Trainor et al, 1990; Deane et al,
1991; Ramasamy et al, 1992; Segal et al, 1994a, b; Lombardo et al,
1996; Essop et al, 1997) (Table III). Although we used this
method to con®rm PCR ampli®cation of the correct product, it
was impossible to distinguish a monoclonal from a polyclonal
product in all but four samples. In other studies nondenaturing
polyacrylamide gel electrophoresis with ethidium bromide staining
has been used (McCarthy et al, 1990; Trainor et al, 1991; Diss et al,
1993; Aubin et al, 1995; Ritter et al, 1997) with a sensitivity of
approximately 1%±10% (Aubin et al, 1995). Although more time-
consuming, radioactively labeled nucleotides and denaturing
polyacrylamide gel electrophoresis increases the sensitivity to
0.1%±1% (Deane and Norton, 1991; Rosenquist et al, 1999) as in
our study. An increased sensitivity is important in PCBCL because
the clonal population may be very small. We used a modi®cation of
the method employed by Deane et al (Deane and Norton, 1991;
Chim et al, 1996), which produces a ®ngerprint from polyclonal
DNA against which a clonal rearrangement can be detected as a
discrete band. The polyclonal ®ngerprint pattern serves as a
convenient internal control for monitoring the ef®cacy of the PCR
reaction and this con®rmed the presence of ampli®able DNA in all
39 of our cases.
Analysis of ¯uorescent PCR products on automated sequencers
has a similar sensitivity (10-2±10-3) (Landman-Parker et al, 1996) to
our method and is increasingly replacing other methods of
detection. Recently, Derkson et al (1999) compared different
PCR-based approaches to assess clonal IgH gene rearrangements in
B cell neoplasia. They used FR3/JH consensus primers and
compared radiolabeled high resolution ®ngerprinting with non-
denaturing polyacrylamide gel heteroduplex analysis and ¯uores-
cently labeled gene scanning using an automated sequencer. A
clone was detected in 69% with gene scanning compared with 64%
with high resolution ®ngerprinting and 60% with heteroduplex
analysis, suggesting that gene scanning of ¯uorescent PCR products
and automated sequence analysis is the most sensitive method of
detection, but the difference was not statistically signi®cant.
In summary, we have been able to detect a monoclonal B cell
population in 79% of PCBCL using monoplex radiolabeled PCR
and three different sets of consensus primers to amplify the IgH
gene with high resolution ®ngerprint analysis. The leader sequence
primers provided the greatest sensitivity. Sequence analysis con-
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®rmed hypermutation of FR3 primer binding sequences in cases that
produced a false negative result with the FR3 primer. For diagnostic
purposes, initial analysis with the FR3 primer may identify a clonal
IgH rearrangement but, in cases that prove negative, consensus
primers for the leader sequences must be employed.
Fiona J. Child was supported by The Special Trustees of Guy's Hospital and
Dermatrust.
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